Exhibitors Search
인스팜텍
Booth no.
E41
|
Exhibition
|
| |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
|1 Kangwondaehak-gil, Chuncheon-si, Gangwon-do, Republic of Korea |
|
Tel
|
|02-854-1310 |
|
Exhibits
|
| Small molecule-based Long-Acting Macular Degeneration Therapeutics, Disease Modifying Osteoarthritis Drugs, Probiotics Exosome-based Cosmeceutical |
|
Company Type
|
| |
Promotional Video Application Upload
Exhibitor Information
Inspharmtech, Inc. is a biopharmaceutical company that develops first-in-class small-molecule therapeutics for age-related diseases, such as age-related macular degeneration and osteoarthritis. based on disease-oriented drug screening, sustained drug delivery, and PK/PD modeling technologies. In addition, we are developing probiotic-based exosomes as a cosmeceutical for whitening and skin inflammation.
Exhibit/Technology Introduction (General)
1. Biodegradable implants loaded with IPT012 are being developed as a long-acting therapeutic for age-related macular degeneration.
2. IPT015 is being developed as a disease-modifying osteoarthritis drug (DMOAD) with both SC and long-acting formulations.
3. IPT-Exo, an exosome derived from probiotics, has whitening and anti-inflammatory effects.
2. IPT015 is being developed as a disease-modifying osteoarthritis drug (DMOAD) with both SC and long-acting formulations.
3. IPT-Exo, an exosome derived from probiotics, has whitening and anti-inflammatory effects.
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : Small molecule-based Long-Acting Macular Degeneration Therapeutics, Disease Modifying Osteoarthritis Drugs, Probiotics Exosome-based CosmeceuticalSmall molecule-based Long-Acting Macular Degeneration Therapeutics, Disease Modifying Osteoarthritis Drugs, Probiotics Exosome-based Cosmeceutical
KYUNGYON EXHIBITION CORP.
